About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $29.19 (+13.01%)
NBTX NASDAQ Nanobiotix
Nanobiotix share price
Atividade de preço de NBTX
Último preço
$ 29,190
Variação (24h)
3,36 USD (13,01%)
Volume
216.24K
Volume (média 4 sem.)
-
Abertura
$ 26,74
Variação do dia
$ 26,74 - $ 29,92
Fechamento anterior
$ 25,83
Último negócio
22 Oct, 8:00 pm GMT+0
Atrasado
22 Oct, 8:00 pm GMT+0
NBTX price performance
Atrasado
22 Oct, 8:00 pm GMT+0
quote.marketSignals